Furthermore, TP53I13 was shown to be expressed at higher levels in AC-like malignant cells and malignant cells according to the TSICH database, which further emphasized the malignancy of glioma severity and the necessity to find a biomarker for glioma treatment. Here, TP53I13 is linked to central nervous system cancer.